ArticleCancer immunology research2026
Neoadjuvant Endocrine Treatment plus Mammaglobin-A DNA Vaccine Induces Antitumor Immune Responses in the Primary Tumor and Peripheral Blood of Patients with Breast Cancer: Insights from a Phase Ib Clinical Trial.
Rashmi Mishra et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.